Editorial: Special Section on Multiscale Cancer Modeling.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

6 citing papers in PubMed.

1. Optimal Fractionation Scheduling for Radiotherapy Treatments with Reinforcement Learning, Tumor Growth Modeling and Outcome Modeling.Biomedicines · 2025
   Article
2. AI in Medical Imaging Informatics: Current Challenges and Future Directions.IEEE journal of biomedical and health informatics · 2020
   Article
3. Mathematical modeling in cancer nanomedicine: a review.Biomedical microdevices · 2019
   Review
4. Dynamic Targeting in Cancer Treatment.Frontiers in physiology · 2019
   Article
5. An agent-based model for drug-radiation interactions in the tumour microenvironment: Hypoxia-activated prodrug SN30000 in multicellular tumour spheroids.PLoS computational biology · 2018
   Article
6. Coupled Immunological and Biomechanical Model of Emphysema Progression.Frontiers in physiology · 2018
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as